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Highly synergistic antimicrobial 
activity of magainin 2 and PGLa 
peptides is rooted in the formation 
of supramolecular complexes 
with lipids
christopher Aisenbrey1*, Mariana Amaro2*, petr pospíšil2,4, Martin Hof2 & 
Burkhard Bechinger1,3
Magainin 2 and PGLa are cationic, amphipathic antimicrobial peptides which when added as 
equimolar mixture exhibit a pronounced synergism in both their antibacterial and pore-forming 
activities. Here we show for the first time that the peptides assemble into defined supramolecular 
structures along the membrane interface. The resulting mesophases are quantitatively described by 
state-of-the art fluorescence self-quenching and correlation spectroscopies. Notably, the synergistic 
behavior of magainin 2 and PGLa correlates with the formation of hetero-domains and an order-
of-magnitude increased membrane affinity of both peptides. Enhanced membrane association 
of the peptide mixture is only observed in the presence of phophatidylethanolamines but not of 
phosphatidylcholines, lipids that dominate bacterial and eukaryotic membranes, respectively. 
Thereby the increased membrane-affinity of the peptide mixtures not only explains their synergistic 
antimicrobial activity, but at the same time provides a new concept to increase the therapeutic 
window of combinatorial drugs.
Magainin  21,2 and  PGLa3,4 are stored together in the skin of Xenopus laevis frogs where they constitute an impor-
tant part of the innate immune  system5. When added together the two peptides show an order of magnitude 
synergistic enhancement in their antibiotic  activities6–8 as well as in biophysical  assays7. Understanding the 
mechanisms of action of antibiotic peptides and their synergistic or super-additive behavior is of special inter-
est since it helps to guide the development of more potent antibiotics. Many efforts have been made to elucidate 
the structure of a possible complex of magainin 2 and  PGLa8–11 and to correlate those structural features with 
function. The formation of pores by a barrel stave mode of  action12 is the oldest model for antibiotic activity and 
very intuitive. It leads to the “search” for transmembrane configurations, which can be found for PGLa when 
reconstituted into fully saturated artificial model  membranes13,14. However, most cationic amphipathic antibiotic 
peptides adopt stable alignments parallel to the membrane surface and lack the transmembrane configuration 
that is a hallmark of the barrel-stave  model15–17. An instructive example is the antibiotic designer peptide LAH4, 
which adopts an in-planar configuration at low pH and is transmembrane at high  pH18. In contrast to what is 
predicted from a barrel stave model the antibiotic activity of LAH4 is increased at low pH, where the peptide 
is oriented parallel to the membrane  surface19. This and related observations have led to new concepts such as 
the  carpet20 or the detergent  models21. More recently, based on these prior ideas the SMART model has been 
 introduced22 which expands our views much beyond the picture of a pore formed by a transmembrane bundle of 
helical  peptides23. Common to all models is the formation of supramolecular complexes made from antimicrobial 
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peptides and lipids. Thereby causing the membranes to rearrange in shape and packing the peptides tend to 
disrupt the integrity of the lipid bilayer.
Notably the influence of magainin 2 on the alignment of PGLa within the membrane depends on the satura-
tion of the lipids used for the  experiments14,24,25. In addition, the synergistic behavior of magainin 2 and PGLa 
has been shown to depend on the intrinsic curvature of the  bilayer26. Considering the high content of phos-
phoethanolamine (PE) in bacterial  membranes27, POPE/POPG bilayers represent a good model to investigate 
antibacterial activities by biophysical approaches. Both findings are indicators of an important role of the lipids 
that goes beyond the idea that they merely constitute a two dimensional liquid which accommodates active 
protein  components28. Lipids can mediate peptide  interactions24 or form lipid/peptide  supercomplexes29. Direct 
peptide-peptide interactions, such as salt bridges/Coulomb interactions or in-membrane GxxxG dimerization 
 motives30, might also contribute to the formation of  complexes31.
Therefore, here we focus on the characterization of the supramolecular complexes without assumptions about 
the existing models for antibiotic activity. Highly dynamic supramolecular complexes are difficult to grasp, but 
fluorescence correlation spectroscopy (FCS) and fluorescence self-quenching  techniques32 allow the characteri-
zation of the nanoscale environment surrounding the peptides. Beyond structural aspects, we investigate the 
thermodynamics of the interaction of magainin 2, PGLa and lipid bilayers. Furthermore, a quantitative descrip-
tion of the packing and clustering of peptide molecules at the membrane surface is obtained. Finally, the findings 
are put into perspective relative to different models previously developed for antibiotic  action20.
Results
Titrations of magainin 2 and PGLa in presence of GUVs (POPE/POPG, 2/1 mol/mol) were performed in com-
bination with z-scan FCS. The FCS technique is sensitive to the diffusion of the (labeled) magainin 2 and PGLa 
peptides on the surface of the GUVs and allows to quantify the surface concentration of the moving particles 
(peptides). For such experiments magainin 2 was labeled with BODIPY 650/665-X (Mag2-r) and PGLa was 
labeled with FluoProbes FL SE (PGLa-g), two chromophores with distinct emission spectra and no significant 
FRET. The measurements were performed above the gel-to-liquid crystalline phase transition of this lipid mix-
ture, which occurs at about 21 °C27.
The surface concentration of membrane-bound Mag2-r was quantified in the presence of increasing amounts 
of PGLa. The samples consisted of approximately 16 nmol (58 µM) of lipids in the form of GUVs and an initial 
solution concentration of 12.8 nM (3.5 pmol) of Mag2-r, to which PGLa was titrated and gently mixed. At each 
titration step the system was allowed to equilibrate for 15 min before each measurement. Results from the titra-
tion with unlabeled PGLa are shown in Fig. 1A and results for titration with labeled PGLa in supplementary 
Figure S1.
The titration experiment showed that the amount of Mag2-r bound to the POPE/POPG membrane surface 
depends in a linear fashion (in this regime) on the solution concentration of PGLa with a proportionality factor 
of (0.47 ± 0.06) × 10–6 m. Additionally, the amount of PGLa-g particles bound to the bilayer varied in a linear 
fashion with the increase in the final solution concentration of PGLa-g by a factor of (1.04 ± 0.07) × 10–6 m (SI 
Figure S1). In inverse titration experiments, the amount of PGLa-g bound to the lipid membrane was quantified 
for increasing amounts of magainin 2, either labeled or unlabeled (Fig. 1B). The samples consisted of approxi-
mately 16 nmol (58 µM) of lipids in the form of GUVs and an initial solution concentration of 12.8 nM (3.5 pmol) 
of PGLa-g, to which magainin 2 was titrated. In contrast to the behavior of magainin 2, where PGLa added to 
Figure 1.  (A) Surface concentration (pmol/m2) of bilayer-associated red particles (i.e. diffusing particles of 
Mag2-r) as a function of the solution concentration (nM) of unlabeled PGLa. The Mag2-r concentration in 
solution is (approximately) constant at 13 nM. (B) Surface concentration (pmol/m2) of bilayer-associated green 
particles (i.e. diffusing particles of PGLa-g) as a function of the solution concentration (nM) of magainin 2 
(labeled or unlabeled). The PGLa-g concentration in solution is (approximately) constant at 13 nM. Experiments 
were performed at 24 °C.
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the solution helps in membrane association of magainin 2 (Fig. 1A), the amount of bound PGLa-g particles was 
independent on the presence of magainin 2 (Fig. 1B.).
From the titrations performed with both labeled peptides it was possible to assess how the increase of mem-
brane bound Mag2-r is directly related to the amount of membrane bound PGLa-g, (Fig. 2). Linear fitting of 
the data showed that the surface concentration of red particles (Mag2-r) on the lipid membrane was directly 
proportional to the surface concentration of bound green particles (PGLa-g) by a factor of 0.57 ± 0.05.
Fluorescence cross-correlation spectroscopy (FCCS) experiments allow one to identify whether the two dif-
ferent peptides (i.e. Mag2-r and PGLa-g) form complexes or supramolecular structures. Co-diffusion of Mag2-r 
and PGLa-g as one entity (supramolecular structure) causes a correlation in the fluorescence signals detected 
in independent red and green channels, giving rise to a positive cross-correlation, that is, Grg(τ) > 1. Figure 3A 
shows an example of the autocorrelation functions for PGLa-g (green) and Mag2-r (red), and the cross-correla-
tion function (blue). Figure 3B depicts only the cross-correlation functions recorded in different experiments.
The FCCS data showed that there is cross-correlation between the fluorescence signals of PGLa-g and Mag2-
r (further cross-correlation results Grg(τ) at higher peptide concentrations are shown in SI Figure S2). This 
unequivocally shows the formation of supramolecular assemblies involving PGLa-g and Mag2-r that diffuse 
within the lipid membrane as one entity for a least several milliseconds.
Fluorescence self-quenching occurs when two fluorophores reside within a critical radius, thereby providing 
information on peptide association. In order to perform such experiments, the peptides were labeled with NBD at 
the amino-terminus. The fluorescence signal of magainin 2 or PGLa was recorded as a function of dilution with 
unlabeled peptide. Such dilutions series were recorded in the presence of increasing amounts of POPE/POPG 
Figure 2.  Surface concentration (pmol/m2) of red particles (i.e. diffusing Mag2-r particles) associated with 
GUVs made from POPE/POPG 2/1 mol/mol as a function of the surface concentration of bilayer-associated 
green particles (i.e. diffusing PGLa-g particles), during the titration of Mag2-r (concentration in solution 13 nM) 
with PGLa-g. Experiments were performed at 24 °C.
Figure 3.  (A) Typical auto- and cross-correlation functions, G(τ), and (B) cross-correlation functions,  Grg(τ), 
from 1:1 mixtures of PGLa-g and Mag2-r solutions (13 nM) in the presence of 58 µM POPE/POPG (2/1 mol/
mol) in the form of GUVs. Experiments were performed at 24 °C.
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3/1 (mol/mol) lipid bilayers at 20 °C or 35 °C, i.e. at temperatures close to the gel-to-liquid crystalline phase 
transition or well above it, respectively (Tc ~ 22 °C)27. Finally, the titration series were repeated in the presence 
of the second peptide in its unlabeled form.
The measured intensities (an example is shown in Supplementary Figure S3) were fitted with a Poisson dis-
tribution (Eq. 1) resulting in intensities that have been corrected for self-quenching (Fig. 4). Thus the number 
of neighbors (Fig. 5) within the self-quenching radius of about 1 nm is  obtained32.
The self-quenching corrected intensities (Fig. 4) represent a partition  isotherm32 and the partition coefficients 
were obtained using Eq. 2 (Table 1). Membrane association of magainin 2 followed a smooth function that is 
well described by a partition equilibrium (Eq. 2). Interestingly, the presence of PGLa increased the binding of 
magainin 2 at both 20 °C and 35 °C. The partition coefficients were in the range 14,000 M−1 (20 °C) and 3,400 M−1 
(35 °C) in the absence of PGLa; the constants increased to 34,000 M−1 (20 °C) and 46,000 M−1 (35 °C) in the 
presence of PGLa.
The binding isotherm of PGLa was almost linear up to saturation/complete adsorption. Hence the binding 
seemed to be governed by limited surface area (crowding) rather than by the free energy of  binding33,34. The 
curves were poorly described by Eq. 2. Nevertheless, fitting leads to values that allow for a comparison of the 
association with lipid bilayers. The membrane affinity of PGLa was highly dependent on the temperature. At 20 °C 
Figure 4.  Dilution corrected and normalized intensity of (A) 10 µM magainin 2 in the presence (red) or 
absence (black) of 10 µM PGLa and (B) 10 µM PGLa in the presence (red) or absence (black) of 10 µM 
magainin 2 at 20 °C (closed symbols) or 35 °C (open symbols) for increasing lipid concentrations (POPE/POPG, 
3/1 mol/mol).
Figure 5.  Average number of neighbors of (A) 10 µM magainin 2 in the presence (red symbols) or absence of 
10 µM PGLa (black symbols) and (B) of PGLa in the presence (red symbols) or absence of magainin 2 (black 
symbols) for increasing amounts of lipid (POPE/POPG, 3/1 mol/mol). Measurements were performed at 20 °C 
(closed symbols) or 35 °C (open symbols).
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it was very high (partition coefficient > 200 000 M−1 in presence or absence of magainin 2), and barely covered by 
the titration protocol used here. Increasing the temperature to 35 °C significantly reduced the membrane affinity 
of PGLa and a partition coefficient of 530 M−1 was obtained. The presence of magainin 2 increased membrane 
association again to reach a partition coefficient in the range of 6,200 M−1.
The number of neighbors within the self-quenching radius of 1 nm32 calculated from the dilution series of the 
labeled peptides (Fig. 5) showed that at 20 °C the addition of lipid vesicles to magainin 2 rapidly increases the 
number of neighbors of magainin 2 to ~ 1.0 (Fig. 5A; closed black symbols). Above about 20 µM lipid (P/L = 1/2) 
the number of neighbors decreases with increasing lipid concentration in a smooth manner towards a plateau 
around an average of 0.5 neighbors indicating clustering even in the presence of excess lipid. Using the data 
presented in Fig. 5A the number of peptides per  nm2 of lipid surface (assuming 68 Å2 per lipid molecule) was 
calculated (Fig. 6). The subsequent titration steps of increasing amounts of lipid appear from right to left in this 
diagram. A linear fit indicated an extrapolation of ~ 0.44 neighbors at infinite dilution at 20 °C (Table 2). The 
presence of equimolar amounts of PGLa results in a higher maximum number of neighbors of 1.5 at 20 µM of 
lipids (Fig. 5A). Analyzing the number of peptides per membrane surface shows that PGLa barely influences 
the packing of magainin 2 at low coverage, but allows a denser packing at higher magainin 2 coverage of the 
membrane surface (Fig. 6). Due to the reduced membrane affinity such high densities of magainin 2 at the mem-
brane surface did not occur in the absence of PGLa under the conditions used in the experiments. At 35 °C the 
Table 1.  Apparent partition coefficients of the indicated peptide to POPE/POPG 3/1 (mol/mol) vesicles. The 
adsorption isotherms of Fig. 4 were used for the fitting.
Apparent partition coefficient  (M−1) 20 °C 35 °C
Magainin 2 in absence of PGLa 14,050 ± 950 3,380 ± 330
Magainin 2 in presence of PGLa 34,000 ± 5,090 46,000 ± 11,000
PGLa in absence of magainin 2 > 200,000 530 ± 137
PGLa in presence of magainin 2 > 200,000 6,200 ± 3,100
Figure 6.  A. Average number of neighbors of 10 µM magainin 2 in presence (red symbols) or absence of 10 µM 
PGLa (black symbols). B. Average number of neighbors of 10 µM PGLa in presence (red symbols) or absence 
of 10 µM magainin 2 (black symbols). The lines correspond to linear fits below 0.05 peptides per  nm2 of lipid 
surface. Measurements were performed at 20 °C (closed symbols) or 35 °C (open symbols).
Table 2.  Extrapolation of the number of neighbors for infinite dilutions (Fig. 6).
Number of neighbors at infinite dilution 20 °C 35 °C
Magainin 2 without PGLa 0.44 ± 0.02 0.30 ± 0.02
Magainin 2 with PGLa 0.49 ± 0.01 0.37 ± 0.08
PGLa without magainin 2 0.31 ± 0.03 0.92 ± 0.12
PGLa with magainin 2 0.19 ± 0.03 0.76 ± 0.10
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number of neighbors of magainin 2 was significantly reduced in presence and especially in the absence of PGLa. 
In the absence of PGLa the number of neighbors increased at lower peptide coverage (Figs. 5A, 6A), which at 
first glance seems paradoxal. In the presence of PGLa the number of neighbors of magainin 2 was also increased 
at 35 °C when compared to the absence of PGLa. Extrapolation to infinite dilution (Fig. 6A) results in 0.3 and 
0.37 neighbors in the absence or presence of PGLa, respectively. 
The number of neighbors of PGLa on the membrane surface for increasing amounts of lipids displayed quite 
unique features (Fig. 5B). At low P/L ratio the presence of magainin 2 increased the number of neighbors of 
PGLa. However, the scattering of data made a more quantitative analysis of Fig. 5B difficult. Extrapolation to high 
dilution at 20 °C resulted in 0.31 (absence of magainin 2) and 0.19 neighbors (presence of magainin 2) indicat-
ing the formation of peptide clusters even when lipid is in excess. Upon increasing the temperature to 35 °C the 
packing of PGLa on the membrane surface dramatically changed (Figs. 5B, 6B, open symbols). Down to a P/L 
ratio of about 1/40 (up to a lipid concentration of 300 µM) no self-quenching could be detected indicating that 
the peptides were distributed in such a manner that their amino termini are at least 1 nm apart. Only at higher 
peptide dilution PGLa-PGLa contacts could be detected. Extrapolation lead to a number ~ 0.92 neighbors at 
infinite dilution (Fig. 6B, Table 2), although such linear extrapolation may exaggerate this value. The addition 
of magainin 2 resulted in self-quenching already at lower lipid concentrations (Figs. 5B, 6B, open red symbols), 
which was increased by higher dilution of the peptides on the membrane surface. The number of neighbors lev-
eled off at ~ 0.76 for high peptide dilution.
The unique features of PGLa in POPE/POPG 3/1 (mol/mol) at different temperatures requested additional 
investigations. We performed 15N solid-state NMR investigations of  [15N-Ala14]-PGLa incorporated into uni-
axially oriented POPE/POPG 3/1 (mol/mol) membranes (P/L = 2%) in the presence of equimolar amounts of 
unlabeled magainin 2 (Fig. 7). When the supported lipid bilayer sample is inserted into the NMR coil with its 
normal parallel to the magnetic field direction, transmembrane helical peptides exhibit 15N chemical shifts 
around 200 ppm whereas amphipathic helices oriented parallel to the membrane surface resonate < 100 ppm35. 
At 35 °C (Fig. 7A), the spectrum showed a single peak at 67 ppm indicating an in-planar alignment of the pep-
tide. At 20 °C, the 15N solid state NMR spectrum (Fig. 7B) became relatively broad with contributions between 
60 and 225 ppm and maxima at ~ 80 ppm and 210 ppm. This indicated the presence of many different orienta-
tions of the peptide. At 5 °C (Fig. 7C) the peak at 80 ppm became sharper. Verification of the alignment of the 
phospholipid bilayers by 31P solid-state NMR spectroscopy showed that the lipids were predominantly oriented 
with their long axis parallel to the magnetic field (Figure S4).
Discussion
Fluorescence self-quenching experiments at different temperatures as well as FCS titration experiments consist-
ently show an increased membrane affinity of magainin 2 in the presence of PGLa. The apparent partition coef-
ficient of magainin 2 to POPE/POPG 3/1 (mol/mol) vesicles significantly increases by 2–3 fold at 20 °C and more 
than tenfold at 35 °C due to the presence of equimolar amounts of PGLa (Table 1). High membrane-association 
constants of 76 600 M−1 for magainin 2 and 320 000 M−1 for PGLa insertion into POPE/POPG 3/1 (mol/mol) 
have been measured before using ITC at 35 °C36, while CD titrations at 25 °C have suggested that the association 
of PGLa to this bacterial membrane mimetic is electrostatically driven and saturates in a sudden manner upon 
charge  neutralization37. However, the domination of electrostatic interactions in the CD experiments is related to 
the low ionic strength (absence of salt) used in the experiments and can be reproduced in self-quenching experi-
ments under the same conditions (Figure S7). Temperature has a modest effect on the affinity of magainin 2, when 
compared to the addition of PGLa, even though the lipids change from a liquid crystalline phase at 35 °C to a 
mixed liquid/gel phase at 20 °C27. The FCS data shows a clear linear correlation between the solution concentra-
tion of PGLa and the concentration of magainin 2 on the membrane surface (Fig. 1A). The data also suggest that 
two PGLa peptides are needed to help in the membrane association of one magainin 2 (proportionality factor 
of 0.57). Hence, the FCS data confirms that PGLa increases the membrane affinity of magainin 2. This is in line 
with previous findings showing that magainin exhibits a propensity to self-associate into dimers in membrane 
mimetic  environments38 leading to a self-cooperative membrane absorption  behavior39.
Notably a three to tenfold increase of the apparent association constant results in a correspondingly higher 
increased surface concentration of the peptides under the conditions of a typical antibiotic assay (see supplemen-
tary discussion). Assuming that the surface concentration is directly related to the bacterial  killing40, this effect 
thereby accounts for an order of magnitude reduction of the  MIC7,41,42 and can explain the synergistic behavior 
of both peptides under typical antibiotic assay conditions.
At 20 °C PGLa has a very high affinity to the lipid membrane, which seems to be little influenced by the 
presence of magainin 2 (Fig. 4B and Table 1). The increased affinity at 20 °C comes together with a change in 
structure from all in-planar at 35 °C to a broad distribution of peptide orientations at 20 °C (Fig. 7), while the 
31P solid-state NMR spectra are indicative of well aligned phospholipid bilayers (supplementary Figure S4). The 
broad distribution of alignments of PGLa represents new membrane states which deplete the in-planar initial 
association state and which allow a higher packing of peptides within the membrane in the sense of molecular 
 crowding33. PGLa has been documented previously to be prone to topological rearrangements in membranes 
made from fully saturated lipids (but not when containing palmitoyl–oleoly fatty acyl chain) as a function of the 
peptide-to-lipid ratio, the presence of magainin 2 and membrane  hydration14,24,25. The disordering of the fatty 
acyl chain packing by molecules intercalating into the membrane interfacial region is particularly pronounced 
for saturated or gel state membranes and has been suggested to be a main driving force for the peptides to adopt 
a transmembrane  state24.
FCCS measurements can directly track supramolecular structures that contain both peptides. FCCS experi-
ments using PGLa-g and Mag2-r unequivocally demonstrate the presence of supramolecular arrangements 
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that diffuse within the lipid membrane as one entity for at least several milliseconds (Fig. 3 and SI Figure S2). 
Fluorescence self-quenching experiments show a clear mutual influence of both peptides in the formation of 
supramolecular structures on the membrane surface (Fig. 6).
When the POPE/POPG membranes are in their liquid crystalline state at 35 °C, the fluorescence quenching 
investigations indicate that both PGLa and magainin 2 have a tendency for supramolecular arrangements at the 
membrane surface where their amino-termini come close to within 1 nm (Fig. 6). Previous 15N solid-state NMR 
investigations have shown that both PGLa and magainin 2 adopt stable alignments parallel to the membrane 
Figure 7.  15N solid-state NMR spectra of  [15N-Ala14]-PGLa (2% P/L ratio) reconstituted into POPE/POPG 
3/1 (mol/mol) bilayers uniaxially oriented with the normal parallel to the magnetic field direction of the NMR 
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surface in liquid crystalline membranes carrying at least one unsaturation per lipid, including POPE/POPG mix-
tures or E.coli lipid  extracts24,42. Therefore, a model emerges where a mesophase arrangement of peptide helices 
with head-to-head alignment brings the amino-terminal ends into close proximity, in similarity to the model 
previously proposed for a designed antimicrobial model peptide  LAH432. The group of Mazuzaki determined 
a magainin 2/PGLa 1:1 molar ratio as the stoichiometry where synergism is  maximal7. A cross-linking study 
with peptides extended at one of their termini with a GGC tripeptide revealed a preferential reaction when the 
cysteines were at the C-termini of both membrane-associated  peptides43. Here, we present data indicating that 
the peptides individually form a mesh-like structure which places the N-terminal fluorophores in close proximity. 
Notably, the average density of neighbors increases when mixed with the other peptide. Salt bridges/Coulomb/
electric dipole interactions might all be important for those contacts as mutations on the C-terminal lysines of 
PGLa and the C-terminal glutamic acid of Mag-2 considerably reduce  synergy7,31.
Clearly, magainin 2 has higher impact on bringing the PGLa amino-termini close to each other when com-
pared to the influence of PGLa on magainin 2. Possibly the negative charge of the E19 residue of magainin 2 has a 
favorable effect on the formation of mesophase arrangements involving the heavily cationic magainin 2 (net + 3) 
and PGLa peptides (net + 4). Furthermore, different insertion depths of magainin 2 and  PGLa10 may have an 
influence on the mesophase arrangement as the packing defects of the fatty acid chains caused by the interfacial 
insertion of the two peptides could partially cancel each other. The self-quenching as well as the FCS studies 
require that the peptides are labeled with a fluorophore which might influence the behavior of the measured 
peptides and thereby affects the experimental observations. However, the clear differences between the results 
obtained with magainin 2 or PGLa confirm the dominating effect of intrinsic peptide properties over the influ-
ence of the labels (Fig. 6). Additionally, PGLa and magainin 2 labeled with fluorophores at their amino-termini 
maintain their antibiotic and synergistic  activity36 albeit with slightly higher absolute MIC values.
Additional fluorescence quenching experiments were performed at ambient temperature (20 °C), a situation 
likely encountered when a frog (i.e. the animal producing and storing these peptides as a cocktail) encounters a 
bacterial infection in a natural  setting1,2,44,45. Because the gel-to-liquid crystalline phase transition occurs at about 
21–22 °C for the POPE/POPG mixtures studied here, these two phases are expected to coexist at 20 °C27. At 20 °C 
the packing of magainin 2 is significantly denser than at 35 °C (Figs. 5A, 6A). The density further increases in the 
presence of PGLa (Fig. 5A) probably as a result of the increased affinity of magainin 2 to the lipid membranes 
in the presence of PGLa (Fig. 6A).
Bearing in mind the complex phase behavior of lipid  mixtures46 it is not surprising that membrane peptides 
exhibit a distinct phase behavior in interplay with the lipids present in the system. Such systems can be described 
theoretically by mean field  models46 applying the molecular theory of  solutions47 to two dimensions. For lipid 
systems Yagi & Sato derived the Kirkwood–Buff (KB) integrals for radial  correlation48 of mixtures of saturated 
and unsaturated lipids.
Notably, for samples where POPE is replaced by POPC (SI Figure S5) the membrane affinities of the two 
peptides are independent of each other. Therefore, the increased membrane affinity of magainin 2 due to the 
presence of PGLa is dependent on the lipid composition of the membranes, namely on the presence of POPE. 
Also clustering of magainin 2 and PGLa both when mixed together and when studied alone is not observed 
in POPC/POPG 1/3 (mol/mol) membranes (SI Figure S6). This suggests that either the H-bonding capacity of 
PE and/or its conical shape and resulting membrane curvature strain are important factors for the formation 
of peptide and possible peptide/POPE clusters. In this context it is of interest that the 2H-order parameters of 
POPE-d31 are considerably more affected by the peptides when compared to POPC-d31 when either deuterated 
lipid is studied in mixed membranes with  POPG24.
In a previous investigation the synergistic activity between magainin 2 and PGLa was related to the negative 
curvature strain imposed on the lipid bilayers due to the presence of POPE lipids, with PGLa possibly being able 
to precondition the membrane for magainin 2  action26. Thus, lipid structure and packing play important roles 
in the interaction of both peptides with the membrane and with each other. Importantly, the features of POPE 
may provide a mechanism for the selective activity of the peptides, since lipids with intrinsic negative curvature, 
such as PE, are enriched in E. coli and other bacterial  membranes49. In addition, the selective killing of bacteria 
is assured by the strong cationic character of the peptides which increases their local concentration in the prox-
imity of the negatively charged bacterial  surface50,51. Lipid-dependent activities of antibiotic peptides have been 
described  before17,26,27,52,53 featuring an “active” role of lipids in the antimicrobial  action22.
conclusion
Both PGLa and magainin 2 form clusters on the membrane surface specifically in the presence of POPE, a lipid 
with a negative intrinsic  curvature27 typical for bacterial membranes. The peptides’ selective action against 
bacteria is assured not only by the negative surface charge of the bacterial outer membrane that increases the 
local concentration of the cationic peptides but also by their clustering in the presence of PE-rich membranes 
as described here. Additionally, our experimental results demonstrate the mutual influence of both peptides 
in the formation of even tighter macromolecular assemblies. Thereby, the lateral organization of peptides adds 
an additional layer of complexity to their mechanism of action. Peptide-rich domains (the hallmark of the car-
pet  model54) probably modify the lipid structure including the lipid fatty acid chain  packing55 and the bilayer 
integrity, as described in the SMART  model22. Interestingly, the mere presence of peptide-induced domains and 
the concomitant domain boundaries may be responsible for increased membrane  permeabilization55–58. Most 
strikingly, when PGLa and magainin 2 are added together to POPE/POPG membranes their affinity to this bac-
terial membrane mimetic is considerably increased, which by itself can explain the synergistic enhancement of 
antibiotic activities observed for the combination of peptides. Notably, the thermodynamic characteristics are 
tightly related to the structural features of the formation of mesophases.
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Methods
Peptide synthesis. The peptides were synthesized as described  in18 following the standard Fmoc-strategy 
using an automatic Milipore 9,050 peptide synthesizer (Millipore cooperation, Bedford, MA, USA) and Fmoc-
protected amino acids (Novabiochem/Merck, Nottingham, UK). The peptide sequences are:
• magainin 2 (Mag 2): GIGKF LHSAK KFGKA FVGEI MNS-carboxyamide.
• PGLa: GMASK AGAIA GKI{15N-A}K VALKA L-carboxyamide.
NBD-labeling. The labeling of the peptides with NBD was performed when still attached to the resin and the 
side chains protected. Therefore, the N-terminus represented the only free amine after cleavage of the final Fmoc 
protection group. 10 equivalents of 4-Chloro-7-nitrobenzofurazan (NBD) (Fluka, Sigma-Aldrich, St. Louis, Mis-
souri, USA) was dissolved in 50% acetonitrile containing 50 mM  NaHCO3 and the resin was incubated for 8 h 
(typically 2 ml/100 mg resin)59. After cleavage from the resin the peptides were purified by reverse phase HPLC. 
The identity and purity of the products were confirmed by MALDI mass spectrometry.
Bodipy labeling. 5 mg of peptide was dissolved in 1 ml of 50% acetonitrile and the pH was adjusted to 6 by 
drop-wise additions of 100 mM NaOH. 0.5 mg of activated BODIPY (FluoProbes FL SE, Interchim, Montlucon, 
France for PGLa and BODIPY 650/655-X, SE Molecular Probes, Eugene, Oregone, US for Mag2) was dissolved 
in 300 µl of 50% acetonitrile. Both solutions were mixed and incubated at 4 °C over night. The product was 
purified by HPLC and identified by mass spectrometry. The attachment to the N-terminus was ensured by the 
relatively low pH value well below the pK of the lysines. In the case of PGLa the attachment of the label to the 
N-terminus was verified by NMR by using a 15N labeled glycine at the N-terminus.
Self-quenching fluorescence measurements. Fluorescence measurements were performed in 10 mM 
Tris pH 7, 1 mM EDTA and 100 mM NaCl. Fluorescence spectroscopy was performed using a FluoroLog spec-
trophotometer (HORIBA, Ltd., Kyoto, Japan) with the polarization filters at the magic angle. The slit size was 
3 nm for excitation and emission. For NBD fluorescence the emission was scanned from 470 to 650 nm at an 
excitation wavelength of 465  nm32.
Self-quenching analysis. For every series of measurements, the label was diluted by replacement of the 
labeled peptide with unlabeled peptides. The resulting series contained 100%, 66.7%, 50%, 33.3% and 20% (per 
mole) of labeled analogues. The intensities at 540 nm for the series were fitted assuming a Poisson distribution 
of the number of  neighbors32:
where  I0 corresponds to the intensity in absence of self-quenching, δ is the average number of neighbors and  
is the fraction of labeling.
Fitting of apparent partition equilibrium:
Partition isotherms were fitted with the equation:
The equation follows directly from the relations:
where k is the equilibrium constant,  [pepbound],  [pepfree], [pep], are the concentration of bound , free and total 
peptide respectively.[lip] is the concentration of lipids,  If is the signal of the free peptide and ΔI is the intensity 
change due to binding.
The equations are formally identical to a binding in the sense of the mass action law. The interpretation of
as the concentration of the peptide within the membrane allows to read the equations as a partition equilibrium.
preparation of small unilamellar vesicles:
POPC, 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (Sigma-Aldrich, St. Louis, Missouri, USA), POPE, 
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (Avanti Polar Lipids, Alabaster, Alabama, USA) and 
POPG, 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-rac-glycerol) (Avanti Polar Lipids, Alabaster, Alabama, 
USA) were co-dissolved in dichloromethane in a small test tube and the solvent was evaporated under a stream 
of nitrogen. The remaining traces of organic solvent were removed by high vacuum overnight. The appropriate 
amount of 10 mM Tris pH 7, 1 mM EDTA and 100 mM NaCl was added in order to obtain a 10 mM lipid sus-
pension. The samples were first vortexed and then homogenized by four freeze–thaw cycles. Small unilamellar 
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vesicles were produced by extrusion 21 times through a poly-carbonate film of 100 nm using a syringe extruder 
(Avanti Polar Lipids, Alabaster, Alabama, USA)60.
Preparation of Giant unilamellar vesicles by gentle hydration. POPE and POPG (2/1 mol/mol) 
were mixed in 1 mL chloroform (approx. 0.28 mg lipid/mL). The solution was dried with a rotary evaporator 
to form a lipid film and then kept under vacuum for 6 h to eliminate all traces of the solvent. The dried film 
was hydrated with 1 mL of pre-warmed buffer (10 mM Tris, 100 mM NaCl, 0.1 M sucrose, pH = 7.1) that had 
been purged with  nitrogen61. The sample was then sealed, heated to 37 °C, kept overnight at this temperature 
and then slowly cooled. The resulting suspension was gently vortexed before further use to disperse the formed 
liposomes. The prepared lipid mixtures contained 2 mol% of biotinyl-Cap-PE necessary for immobilization of 
the giant unilamellar vesicles (GUVs) to BSA-biotin/streptavidin-coated microscopy chambers. To prepare a 
sample for measurement, 40 µL of the GUVs suspension were placed on a microscopy chamber containing 200 
µL of glucose buffer (10 mM Tris pH 7, 100 mM NaCl, 0.1 M glucose). After inspection of the GUVs quality, 
PGLa or/and magainin 2 were added to the chamber at a final concentration of 13 nM each, unless otherwise 
stated. Magainin 2-Bdp650 (Mag2-r) and PGLa-FL (PGLa-g) are used considering 100% labeling and at a 1:1 
ratio (unless otherwise stated). Experiments were performed at 24 °C.
Two-color fluorescence correlation spectroscopy (FCS) measurements. Measurements were 
performed on a home-built confocal microscope consisting of an inverted confocal microscope body IX71 
(Olympus, Hamburg, Germany). Pulsed diode lasers (LDH-P–C-470, 470  nm, and LDH-D-C-635, 635  nm; 
PicoQuant, Berlin, Germany) were used at 10 MHz repetition rate each and pulsed alternatively to eliminate 
cross-talk. Laser light was coupled to a polarization maintaining single mode optical fiber and re-collimated at 
the output with an air space objective (UPLSAPO 4X). The light was up-reflected with a 470/635 dichroic mirror 
onto a water immersion objective (UPLSAPO 60x, Olympus). The fluorescence signal was split between two sin-
gle photon avalanche diodes using 515/50 and 697/58 band pass filters (Chroma Rockingham, VT) for the green 
and red channels, respectively. Laser intensity at the back aperture of the objective was approximately 10 µW for 
each laser. Measurements were performed on the top of selected GUVs. For z-scan  FCS62, the membrane was 
first placed on the waist of the focus of the laser and then moved 1.4 µm above it. A sequential vertical scan of 
20 steps (spaced 150 nm) was then performed, where at each z-position a measurement was taken for 60 s. For 
fluorescence cross-correlation spectroscopy (FCCS) measurements, the membrane was placed on the waist of 
the focus and data was acquired for a period of 5 min on each GUV.
Analysis of the FCS data. The auto-correlation function G(τ) was calculated from the fluorescence inten-
sity traces in each independent channel (red or green) and fitted to a model that includes two- and three-dimen-
sional diffusions, which allows to account for a fraction of unbound peptide remaining in  solution63:
where τD2 and τD3 are the diffusion times of molecules diffusing in two and three dimensions respectively, ω0 
is the waist of the focus (where the intensity has dropped by 1/e2), ωZ is the characteristic axial dimension of 
the detection volume, T is the average fraction of fluorophores in triplet state and τT the intersystem crossing 
relaxation time. F2 is the fraction of molecules diffusing in the two-dimensional space, i.e. membrane bound 
and laterally diffusing. τD2 and τD3 are the diffusion times of the molecules moving in two and three dimensions, 
respectively. τD3 was determined by measurements in bulk solution.
Fitting of each auto-correlation function obtained during the z-scan retrieves the τD2, particle numbers N and 
the fraction of membrane-associated molecules. The surface concentrations C of the labeled peptides were deter-
mined by fitting the plot of N against the focus position z to a parabolic dependency, as detailed in Benda et al.62:
where n is the refractive index of the medium, λ is the wavelength of the excitation light, and ∆z is the distance 
between the sample position z0 and the position of the beam diameter minimum z.
The cross-correlation function  Grg(τ) was calculated from the intensity traces in the red and green channels.
Uniaxially oriented samples for solid state NMR spectroscopy. 37 mg of POPE and 13 mg of POPG 
(POPE/POPG 3/1 mol/mol) were co-dissolved with 0.7 mg  [15N-Ala14]-PGLa (2%) and 0.8 mg of magainin 2 
(2%) in chloroform methanol 3/1. All peptides were used without any fluorescence label attached. The volume 
was reduced with a stream of nitrogen and the solution distributed on 20 ultrathin cover plates (13 × 8 mm) 
(Marienfeld GmbH, Lauda-Königshofen, Germany). The samples were first dried on air and then overnight in 
high vacuum. After rehydration in 93% humidity the glass plates were stacked, the stack was stabilized by Teflon 
tape and sealed in Plastic (Escal neo, Mitsubishi Gas Chemical Company Inc. Tokio, Japan).





















































Scientific RepoRtS |        (2020) 10:11652  | https://doi.org/10.1038/s41598-020-68416-1
www.nature.com/scientificreports/
Solid-state NMR spectroscopy. Proton decoupled 15N spectra were recorded using a simple cross-polar-
ization experiment on a 750 MHz wide bore NMR spectrometer (Bruker Biospin, Karlsruhe, Germany) with 
a B1 field of 50 kHz for both the proton Pi pulse and the CP step of 400 µs. Typically 20,000 scans were accu-
mulated. Proton decoupled 31P spectra were recorded on a 300 MHz wide bore NMR spectrometer (Bruker, 
Karlsruhe Germany) using a hahn echo experiment of 10 µs echo time. The 31P B1 fields were 83 kHz and 64 
scans were accumulated.
Mag2-r titrated with PGLa-g. Mag2-r (3.5 pmol, solution concentration of 12.8 nM) was added to sam-
ples containing 16 nmol of lipids as GUVs (58 µM). This sample was then titrated with PGLa-g. The last sample 
corresponds to the same conditions used for samples A of the FCCS measurements, 13 nM of each peptide and 
58 µM of lipids. The measurements are made in two-colour mode, i.e., data is obtained simultaneously for both 
peptides, for each particular GUV.
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